Parham, Groesbeck P.
Egemen, Didem
Befano, Brian
Mwanahamuntu, Mulindi H.
Rodriguez, Ana Cecilia
Antani, Sameer
Chisele, Samson
Munalula, Mukatimui Kalima
Kaunga, Friday
Musonda, Francis
Malyangu, Evans
Shibemba, Aaron Lunda
de Sanjose, Silvia
Schiffman, Mark
Sahasrabuddhe, Vikrant V.
Funding for this research was provided by:
National Cancer Institute
Article History
Received: 2 June 2023
Accepted: 13 September 2023
First Online: 16 October 2023
Declarations
:
: The study was approved by the University of Zambia Biomedical Research Ethics Committee, the Zambian National Health Research Agency, and the Institutional Review Board of the University of North Carolina, Chapel Hill. All study participants were provided a full explanation of the study, along with its risks and benefits, in their native language. They were enrolled in the study only after signing the consent form.
: No individually identifiable data is included in the manuscript.
: The authors declare that they have no competing interests.